LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

2,564
Mkt Cap
$4.06B
Volume
234,918.00
52W High
$212.49
52W Low
$93.58
PE Ratio
99.18
LGND Fundamentals
Price
$199.03
Prev Close
$206.05
Open
$209.13
50D MA
$184.31
Beta
0.97
Avg. Volume
141,175.57
EPS (Annual)
-$0.2204
P/B
4.26
Rev/Employee
$2.46M
Loading...
Loading...
Latest Earnings Results: Q3 '25
Reported: Nov 06

Estimated EPS

$1.93

Reported EPS

$3.09

Surprise

+60.24%

Estimated Rev

$58.74M

Reported Rev

$115.46M

Surprise

+96.55%

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '25
$1.54
--
--
N/A
Q3 '25
$1.93
$3.09
60.24%
BEAT
Q2 '25
$1.42
$1.60
12.56%
BEAT
Q1 '25
$1.21
$1.33
9.77%
BEAT
Q4 '24
$1.16
$1.27
9.67%
BEAT

Latest LGND News

View

Advertisement|Remove ads.

Advertisement|Remove ads.